Cargando…
Safety of COVID-19 vaccination in patients with clonal mast cell disorders
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806141/ https://www.ncbi.nlm.nih.gov/pubmed/35121156 http://dx.doi.org/10.1016/j.jaip.2022.01.030 |
| _version_ | 1784643378052333568 |
|---|---|
| author | Ruano-Zaragoza, Maria Carpio-Escalona, Laura V. Diaz-Beya, Marina Piris-Villaespesa, Miguel Castaño-Diez, Sandra Muñoz-Cano, Rosa González-de-Olano, David |
| author_facet | Ruano-Zaragoza, Maria Carpio-Escalona, Laura V. Diaz-Beya, Marina Piris-Villaespesa, Miguel Castaño-Diez, Sandra Muñoz-Cano, Rosa González-de-Olano, David |
| author_sort | Ruano-Zaragoza, Maria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8806141 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Academy of Allergy, Asthma & Immunology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88061412022-02-02 Safety of COVID-19 vaccination in patients with clonal mast cell disorders Ruano-Zaragoza, Maria Carpio-Escalona, Laura V. Diaz-Beya, Marina Piris-Villaespesa, Miguel Castaño-Diez, Sandra Muñoz-Cano, Rosa González-de-Olano, David J Allergy Clin Immunol Pract Clinical Communications American Academy of Allergy, Asthma & Immunology 2022-05 2022-02-01 /pmc/articles/PMC8806141/ /pubmed/35121156 http://dx.doi.org/10.1016/j.jaip.2022.01.030 Text en © 2022 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Clinical Communications Ruano-Zaragoza, Maria Carpio-Escalona, Laura V. Diaz-Beya, Marina Piris-Villaespesa, Miguel Castaño-Diez, Sandra Muñoz-Cano, Rosa González-de-Olano, David Safety of COVID-19 vaccination in patients with clonal mast cell disorders |
| title | Safety of COVID-19 vaccination in patients with clonal mast cell disorders |
| title_full | Safety of COVID-19 vaccination in patients with clonal mast cell disorders |
| title_fullStr | Safety of COVID-19 vaccination in patients with clonal mast cell disorders |
| title_full_unstemmed | Safety of COVID-19 vaccination in patients with clonal mast cell disorders |
| title_short | Safety of COVID-19 vaccination in patients with clonal mast cell disorders |
| title_sort | safety of covid-19 vaccination in patients with clonal mast cell disorders |
| topic | Clinical Communications |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806141/ https://www.ncbi.nlm.nih.gov/pubmed/35121156 http://dx.doi.org/10.1016/j.jaip.2022.01.030 |
| work_keys_str_mv | AT ruanozaragozamaria safetyofcovid19vaccinationinpatientswithclonalmastcelldisorders AT carpioescalonalaurav safetyofcovid19vaccinationinpatientswithclonalmastcelldisorders AT diazbeyamarina safetyofcovid19vaccinationinpatientswithclonalmastcelldisorders AT pirisvillaespesamiguel safetyofcovid19vaccinationinpatientswithclonalmastcelldisorders AT castanodiezsandra safetyofcovid19vaccinationinpatientswithclonalmastcelldisorders AT munozcanorosa safetyofcovid19vaccinationinpatientswithclonalmastcelldisorders AT gonzalezdeolanodavid safetyofcovid19vaccinationinpatientswithclonalmastcelldisorders |